Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Double-Blind Placebo-Controlled Study of ITK-1 in Prostate Cancer
jRCT2080222153Phase 3Completed
- Start
- Jul 2013
- Modality
- Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in prostate cancer (PCa) comparing ITK-1 peptide vaccine with Placebo (2 arms). Started Jul 2013; status: completed.
02
Drugs
ITK-1
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT2080222153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222153.